Recent from talks
Veranova
Knowledge base stats:
Talk channels stats:
Members stats:
Veranova
Veranova, L.P. (formally Johnson Matthey Health) is an American multinational contract development and manufacturing organization (CDMO) based in Devens, MA, with operations in North America and Europe.
The company focuses on the process, development, and manufacturing of active pharmaceutical ingredients (APIs), particularly specialty and highly regulated, complex chemistries. It has two divisions, Generics and Originators. Its specialized drug development and manufacturing technologies and expertise in the pharmaceutical and biotechnology industries span the drug development lifecycle.
Johnson Matthey Health was purchased in 2022 by Altaris Capital Partners for £325 million (JM retaining 30% equity) and rebranded to become Veranova; the name originates from the combined Latin words ‘vērus’, meaning ‘true’, and ‘nŏvus’, meaning ‘new’.
Through its original founding companies, the history of Veranova can be dated back to 1780, when the Edinburgh apothecary supplier, J.F. Macfarlan, was founded. In 1815, John Fletcher Macfarlan, a licentiate of the Membership of the Royal Colleges of Surgeons, became the owner of the family business and acquired the apothecary shop on Edinburgh’s High Street where he began manufacturing the opium derivative laudanum. In 1830, a partnership was established with Macfarlan’s former apprentice, David Rennie Brown, and the business became J. F. Macfarlan and Co. By 1832, J.F. Macfarlan and Co. was manufacturing morphine acetate (medicinal heroin) and hydrochloride, resulting in the development and production of anesthetics including synthetic chloroform and diethyl ether. J.F. Macfarlan collaborated with Joseph Lister, known as the father of modern surgery, to start production of the first sterile dressings in 1870.
In 1827, Thomas and Henry Smith established T&S Smith. Initially producing photographic paper and chemicals, it went on to be the first business to develop apomorphine in large amounts for commercial use. Not long after T&S Smith was established, William Flockhart, an Edinburgh-based pharmacy, started manufacturing chloroform and laudanum.
In 1817, Percival Norton Johnson set up a gold assaying business in London, and in 1851, George Matthey joined, forming Johnson Matthey (JM).
During World War I, T&H Smith and Duncan Folkhart produced morphine and chloroform for medicinal purposes. Throughout the war, J.F. Macfarlan produced approximately 200 tonnes of medicated lint, 7.5 million bandages, and 1477 kilometers of gauze. In 1952, T&H Smith bought Duncan Flockhart and rebranded it as Smith Duncan Flockhart. It went on to produce Bitrex (denatonium benzoate), the world's most bitter substance in 1958.
In 1962, Smith Duncan Flockhart merged with J.F. Macfarlan to form Edinburgh Pharmaceuticals, which in 1965 was bought by Glaxo Group and rebranded as Macfarlan Smith Ltd.
Hub AI
Veranova AI simulator
(@Veranova_simulator)
Veranova
Veranova, L.P. (formally Johnson Matthey Health) is an American multinational contract development and manufacturing organization (CDMO) based in Devens, MA, with operations in North America and Europe.
The company focuses on the process, development, and manufacturing of active pharmaceutical ingredients (APIs), particularly specialty and highly regulated, complex chemistries. It has two divisions, Generics and Originators. Its specialized drug development and manufacturing technologies and expertise in the pharmaceutical and biotechnology industries span the drug development lifecycle.
Johnson Matthey Health was purchased in 2022 by Altaris Capital Partners for £325 million (JM retaining 30% equity) and rebranded to become Veranova; the name originates from the combined Latin words ‘vērus’, meaning ‘true’, and ‘nŏvus’, meaning ‘new’.
Through its original founding companies, the history of Veranova can be dated back to 1780, when the Edinburgh apothecary supplier, J.F. Macfarlan, was founded. In 1815, John Fletcher Macfarlan, a licentiate of the Membership of the Royal Colleges of Surgeons, became the owner of the family business and acquired the apothecary shop on Edinburgh’s High Street where he began manufacturing the opium derivative laudanum. In 1830, a partnership was established with Macfarlan’s former apprentice, David Rennie Brown, and the business became J. F. Macfarlan and Co. By 1832, J.F. Macfarlan and Co. was manufacturing morphine acetate (medicinal heroin) and hydrochloride, resulting in the development and production of anesthetics including synthetic chloroform and diethyl ether. J.F. Macfarlan collaborated with Joseph Lister, known as the father of modern surgery, to start production of the first sterile dressings in 1870.
In 1827, Thomas and Henry Smith established T&S Smith. Initially producing photographic paper and chemicals, it went on to be the first business to develop apomorphine in large amounts for commercial use. Not long after T&S Smith was established, William Flockhart, an Edinburgh-based pharmacy, started manufacturing chloroform and laudanum.
In 1817, Percival Norton Johnson set up a gold assaying business in London, and in 1851, George Matthey joined, forming Johnson Matthey (JM).
During World War I, T&H Smith and Duncan Folkhart produced morphine and chloroform for medicinal purposes. Throughout the war, J.F. Macfarlan produced approximately 200 tonnes of medicated lint, 7.5 million bandages, and 1477 kilometers of gauze. In 1952, T&H Smith bought Duncan Flockhart and rebranded it as Smith Duncan Flockhart. It went on to produce Bitrex (denatonium benzoate), the world's most bitter substance in 1958.
In 1962, Smith Duncan Flockhart merged with J.F. Macfarlan to form Edinburgh Pharmaceuticals, which in 1965 was bought by Glaxo Group and rebranded as Macfarlan Smith Ltd.